A generic alternative indicated for Neurology. Targeted support assists with the replenishment of missing dopamine in the brain, facilitating improved motor control and mobility in patients.
A dopamine precursor formulated to manage Parkinson's disease and designed to alleviate motor symptoms to support improved mobility and target better control.
Mechanism of Action
Levodopa crosses the blood-brain barrier and is converted to dopamine. Carbidopa prevents peripheral conversion, reducing side effects and allowing more levodopa to reach the brain.
Route of Administration
Oral
Onset Time
30 minutes
Duration
3–5 hours
Contraindications
Narrow-angle glaucoma, History of melanoma, Use of non-selective MAOIs
Information for Carbidopa with Levodopa is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
